E.I.D.- Parry (India) Limited (NSE:EIDPARRY)
837.20
-8.15 (-0.96%)
Apr 29, 2026, 3:30 PM IST
E.I.D.- Parry (India) Revenue
E.I.D.- Parry (India) had revenue of 103.16B INR in the quarter ending December 31, 2025, with 18.29% growth. This brings the company's revenue in the last twelve months to 374.75B, up 23.46% year-over-year. In the fiscal year ending March 31, 2025, E.I.D.- Parry (India) had annual revenue of 316.09B with 7.46% growth.
Revenue (ttm)
374.75B
Revenue Growth
+23.46%
P/S Ratio
0.40
Revenue / Employee
157.19M
Employees
2,300
Market Cap
150.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 316.09B | 21.96B | 7.46% |
| Mar 31, 2024 | 294.13B | -58.31B | -16.54% |
| Mar 31, 2023 | 352.44B | 117.23B | 49.84% |
| Mar 31, 2022 | 235.21B | 49.65B | 26.76% |
| Mar 31, 2021 | 185.56B | 14.27B | 8.33% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paradeep Phosphates | 181.80B |
| Chambal Fertilisers and Chemicals | 204.57B |
| Sumitomo Chemical India | 32.34B |
| Sharda Cropchem | 50.31B |
| Rashtriya Chemicals and Fertilizers | 166.29B |
| Rallis India | 28.71B |
| Kaveri Seed Company | 13.78B |
| Madhya Bharat Agro Products | 17.69B |
E.I.D.- Parry (India) News
- 2 months ago - E.I.D.- Parry (India) Transcript: Q3 25/26 - Transcripts
- 6 months ago - E.I.D.- Parry (India) Transcript: Q2 25/26 - Transcripts
- 9 months ago - E.I.D.- Parry (India) Transcript: Q1 25/26 - Transcripts
- 1 year ago - E.I.D.- Parry (India) Transcript: Q4 24/25 - Transcripts
- 1 year ago - E.I.D.- Parry (India) Transcript: Q3 24/25 - Transcripts